‹ IBRX latest research

IBRX (ImmunityBio, Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed IBRX on 4 market nights between August 28, 2026 and October 12, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

4 calls 0 BUY · 4 HOLD · 0 SELL
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
October 12, 2026 HOLD $10.51 $12.36 / $8.93 not yet not yet
The post-earnings drift signal suggests a short-to-medium term upward move, but the high risk and neutral technicals warrant caution.
October 6, 2026 HOLD $10.38 $12.50 / $8.82 +1.1% not yet
The post-earnings drift suggests a short-term upward trend that may continue for a few weeks.
August 31, 2026 HOLD $8.05 — / — +4.3% +11.1%
The stock is currently in a neutral technical state and does not present a clear directional opportunity.
August 28, 2026 HOLD $8.40 — / — +0.4% +5.8%
Continued positive sentiment and analyst ratings for ANKTIVA.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.